Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human antigen-specific CD8+ Tregs in transplantation

ABSTRACT: Human CD8+CD45RClowFoxp3+ Tregs with high tolerogenic activity in humanized mice and defined alloantigen specificity

PROVIDER: PRJEB20793 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptome analysis of naïve Tregs, memory Tregs and CD161+ Tregs

Project description:Transcriptome analysis of naïve Tregs, memory Tregs and CD161+ Tregs

| PRJNA489005 | ENA

Proteomic analysis of rest and activated Tregs

Project description:The aim of the project is to do proteomic analysis of total cell lysate from rest and activated mouse Tregs. The proteomic data were mapped to the Gene Ontology Cellular Component (GOCC)database to obtain the list of membrane proteins on activated Tregs. The set of membrane proteins identified were compared with the potential Siglec-1 counter-receptors on activated Tregs.

2021-04-28 | PXD022259 | Pride

Analysis of CD8+CD45RClow Tregs from CD40Ig allograft recipients versus naive

Project description:This experiment compare the transcriptional profile of CD8+CD45RClow Tregs from naive untreated rats compared to CD40Ig-treated tolerant allograft recipients.

2015-11-30 | E-MTAB-3535 | biostudies-arrayexpress

ATAC-seq data from naïve Tregs, memory Tregs and CD161+ Tregs

Project description:ATAC-seq data from naïve Tregs, memory Tregs and CD161+ Tregs

| PRJNA489004 | ENA

TIGIT+ Tregs

Project description:TIGIT+ Tregs suppress Th1 and Th17 responses while sparing Th2 responses. Analysis of global gene expression of TIGIT+ vs. TIGIT- Tregs from naive mice reveled that TIGIT+ Tregs display an activated phenotype and are enriched for Treg signature genes including the Treg effector molecule Fgl2 which enables them to selectively spare Th2 responses. TIGIT+ and TIGIT- Tregs were sorted from naïve Foxp3-GFP KI mice (pooled spleen and lymph nodes) TIGIT: T cell immunoreceptor with Ig and ITIM domains

2014-12-12 | E-GEOD-56299 | biostudies-arrayexpress

RNA-seq analysis of human antigen-specific type 1 regulatory T cells (Tr1)

Project description:Co-culture of human CD4+ T cells with allogeneeic tolerogenic dendritic cells (DC-10) results in a cell product, called T-allo10, enriched with alloantigen-specific type 1 regulatory T cells (Tr1 cells). CD49b+LAG3+ Tr1 cells and CD49b-LAG3- non-Tr1 cells (DN) were sorted from total T-allo10 cells, and their transcriptomes compared to parental CD4+ T cells, as well as to and control CD49b-LAG3- effector T cells (Teff) sorted from T-allo cells, which were made equivalently to T-allo10 except with using mature dendirtic cells instead of DC-10.

2021-10-27 | GSE160194 | GEO

MOG KO Tregs versus WT Tregs

Project description:Transcriptional comparison of WT Tregs versus MOG KO Tregs

2016-08-31 | GSE79124 | GEO

RNA-seq profile of stimulated Tregs containing co-receptor signaling domain variant chimeric antigen receptors (CARs).

Project description:Initial CAR therapies were designed and tested in conventional T cells, however several recent reports indicate that CAR Tregs may be effective in solid organ transplant or hematopoietic stem cell transplant. Since Tregs have different activation requirements, we sought to characterize the transcriptional profile of Tregs that were transduced with second-generation CARs containing various co-receptor signaling moieties to determine which bestows Tregs with the most desireable properties.

2021-04-03 | GSE136432 | GEO

PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Tregs polarization

Project description:Here, we discovered that the frequency of CD39+γδ Tregs, which positively correlated with poor prognosis, was significantly higher in right-sided colorectal cancer (RSCRC) than in the left-sided CRC (LSCRC). To explore the molecular mechanism leading to the difference of CD39+γδ Tregs derived from RSCRC and LSCRC, we collected fresh tissue samples of RSCRC with high expression of CD39+γδ Tregs and the LSCRC with low expression of CD39+γδ Tregs detected by flow cytometry and identified differential proteins by LC-MS based quantitative proteomic analysis with tandem mass tag (TMT)

2022-02-17 | PXD027323 | Pride

The immune checkpoint B7x promotes tumor-infiltrating tregs and resistance to anti-CTLA-4 therapy.

Project description:Tumor cells inhibit the anti-tumor immune response by expressing immunomodulatory factors and recruiting immunosuppressive cells to their microenvironment. Regulatory T cells (Tregs) are a population of CD4+ T cells that are commonly found in tumors, promoting a tolerogenic microenvironment and aiding in tumor immune evasion. The immune checkpoint ligand B7x is widely expressed in a broad variety of tumor types and is often associated with greater Treg infiltration, but the mechanism by which B7x promotes tumor-infiltrating Tregs is unknown. Here, we recapitulate the B7x-mediated increase in Tregs in murine tumor models and show that B7x promotes conversion of conventional CD4+ T cells into potently suppressive Tregs. We found that B7x induces global transcriptomic changes in Tregs, driving these cells to adopt an activated and suppressive phenotype. Mechanistically, B7x increased Foxp3 transcriptional expression by modulating the Akt/Foxo signaling pathway. Further, we found that expression of B7x by tumor cells reduced the efficacy of anti-CTLA-4 in syngeneic murine models in a Treg-dependent manner, but this resistance phenotype was overcome by combination anti-B7x and anti-CTLA-4 treatment. Put together, B7x mediates a novel Treg-promoting pathway within tumors and is a promising candidate for combination immunotherapy.

2022-04-02 | GSE199751 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data